|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 47, Issue 6 323-325, Copyright © 1997 by American Cancer Society
J. O. Armitage
Treatments for non-Hodgkin's lymphomas vary widely. Because all treatments
are not useful to all patients, the non-Hodgkin's lymphomas must be divided
into clinically relevant subgroups. Previous systems used to subdivide the
non-Hodgkin's lymphomas were based on morphology. Later systems added
immunologic subgrouping. The International Lymphoma Study Group recently
has proposed that lymphomas be grouped as clinical-pathologic entities.
Diagnoses based on this system were much more accurate than those using
previous systems, but much work remains to be done in the classification of
these cancers.
EDITORIALS
The changing classification of non-Hodgkin's lymphomas
This article has been cited by other articles:
![]() |
S. Ben-Haim and P. Ell 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response J. Nucl. Med., January 1, 2009; 50(1): 88 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Savage, M. Chhanabhai, R. D. Gascoyne, and J. M. Connors Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification Ann. Onc., October 1, 2004; 15(10): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. McCormick, M. H. Kumagai, K. Hanley, T. H. Turpen, I. Hakim, L. K. Grill, D. Tuse, S. Levy, and R. Levy Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants PNAS, January 19, 1999; 96(2): 703 - 708. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |